APA (7th ed.) Citation

Ladjevardi, C. O., Skribek, M., Koliadi, A., Rydén, V., El-Naggar, A. I., Digkas, E., . . . Ullenhag, G. J. Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: A retrospective cohort study in patients with advanced cancer. Springer.

Chicago Style (17th ed.) Citation

Ladjevardi, Cecilia Olsson, Marcus Skribek, Anthoula Koliadi, Viktoria Rydén, Ali Inan El-Naggar, Evangelos Digkas, Antonios Valachis, and Gustav J. Ullenhag. Differences in Immune-related Toxicity Between PD-1 and PD-L1 Inhibitors: A Retrospective Cohort Study in Patients with Advanced Cancer. Springer.

MLA (9th ed.) Citation

Ladjevardi, Cecilia Olsson, et al. Differences in Immune-related Toxicity Between PD-1 and PD-L1 Inhibitors: A Retrospective Cohort Study in Patients with Advanced Cancer. Springer.